Key facts
- This page summarizes David R. Dantzker's Form 4 filing for SURMODICS INC (SRDX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 23 Jan 2024, 17:46.
David R. Dantzker - 19 Jan 2024 Form 4 Insider Report for SURMODICS INC (SRDX)
- Reporting relationship
- Director
- Issuer ticker
- SRDX
- Reported as of
- 19 Jan 2024
- Net transaction value
- -$27.41
- SEC form
- 4
- Accepted by SEC
- 23 Jan 2024, 17:46:08 UTC
- Prior SEC filing
- 13 Feb 2023
- Next SEC filing
- 12 Feb 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ John Manders, on behalf of David R. Dantzker
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
David R. Dantzker filed Form 4 for SURMODICS INC (SRDX) on 23 Jan 2024.
Change
- Previous filing in this sequence was filed on 13 Feb 2023.
- Current net transaction value: -$27.41.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SRDX
transaction
Common Stock
Options Exercise
- Transaction value
- $94,171
- Shares
- +3,932
- Change %
- +11%
- Price
- $23.95
- Shares after
- 40,094
- Date
- 19 Jan 2024
- Ownership
- Direct
SRDX
transaction
Common Stock
Tax liability
- Transaction value
- $94,199
- Shares
- -2,773
- Change %
- -6.9%
- Price
- $33.97
- Shares after
- 37,321
- Date
- 19 Jan 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SRDX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -3,932
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 19 Jan 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 3,932
- Exercise price
- $23.95
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
The amount beneficially owned includes 13,969 restricted stock units (RSUs) that vest on service-based vesting dates and 15,415 DSUs that are vested upon issuance, each of which will be settled in shares of the issuer's common stock on a 1 for 1 basis when the reporting person's service as a director ends.
Footnote F2
Fully vested.